[Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
Wang
Lei
L
Heart and Bloodvessel Centre, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Cui
Liang
L
Wei
Jia-ping
JP
Li
Guang-ping
GP
Qi
Guo-xian
GX
Hao
Yu-ming
YM
Wang
Wen-zhi
WZ
Li
Hui-min
HM
Liu
Jun
J
Jiang
Dong-ju
DJ
Zhang
Yu-dong
YD
D000368:Aged; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004280:Dobutamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011724:Pyridazines / Q000008:administration & dosage / Q000627:therapeutic use*; D000077464:Simendan; D016896:Treatment Outcome
D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan; D004280:Dobutamine